1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Pharmaceuticals in the Czech Republic

Pharmaceuticals in the Czech Republic

  • April 2014
  • -
  • MarketLine
  • -
  • 35 pages

Introduction

Pharmaceuticals in the Czech Republic industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2009-13, and forecast to 2018). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Essential resource for top-line data and analysis covering the Czech Republic pharmaceuticals market. Includes market size data, textual and graphical analysis of market growth trends, leading companies and macroeconomic information.

Highlights

*The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare. Market values have been calculated at ex-factory prices (the value at which manufacturers sell the drugs to distributors). Any currency conversions used in the production of this report have been calculated at constant 2013 annual average exchange rates.

*The Czech pharmaceuticals market had total revenues of $3.1bn in 2013, representing a compound annual growth rate (CAGR) of 0.7% between 2009 and 2013.

*

*The performance of the market is forecast to accelerate, with an anticipated CAGR of 3.3% for the five-year period 2013 - 2018, which is expected to drive the market to a value of $3.7bn by the end of 2018.

Features

Save time carrying out entry-level research by identifying the size, growth, and leading players in the pharmaceuticals market in the Czech Republic

Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the pharmaceuticals market in the Czech Republic

Leading company profiles reveal details of key pharmaceuticals market players’ global operations and financial performance

Add weight to presentations and pitches by understanding the future growth prospects of the Czech Republic pharmaceuticals market with five year forecasts

Macroeconomic indicators provide insight into general trends within the Czech Republic economy

Key Questions Answered

What was the size of the Czech Republic pharmaceuticals market by value in 2013?

What will be the size of the Czech Republic pharmaceuticals market in 2018?

What factors are affecting the strength of competition in the Czech Republic pharmaceuticals market?

How has the market performed over the last five years?

Who are the top competitiors in the Czech Republic's pharmaceuticals market?

Table Of Contents

Pharmaceuticals in the Czech Republic
TABLE OF CONTENTS

Executive Summary 2
Market value 2
Market value forecast 2
Geography segmentation 2
Market share 2
Market rivalry 2
Market Overview 7
Market definition 7
Market analysis 7
Market Data 8
Market value 8
Market Segmentation 9
Geography segmentation 9
Market share 10
Market Outlook 11
Market value forecast 11
Five Forces Analysis 12
Summary 12
Buyer power 13
Supplier power 15
New entrants 16
Threat of substitutes 18
Degree of rivalry 19
Leading Companies 20
GlaxoSmithKline Plc 20
Novartis AG 24
Pfizer Inc. 28
Macroeconomic Indicators 31
Country Data 31
Appendix 33
Methodology 33
Industry associations 34
Related MarketLine research 34

LIST OF TABLES

Table 1: Czech Republic pharmaceuticals market value: $ billion, 2009-13 8
Table 2: Czech Republic pharmaceuticals market geography segmentation: $ billion, 2013 9
Table 3: Czech Republic pharmaceuticals market share: % share, by value, 2013 10
Table 4: Czech Republic pharmaceuticals market value forecast: $ billion, 2013-18 11
Table 5: GlaxoSmithKline Plc: key facts 20
Table 6: GlaxoSmithKline Plc: key financials ($) 21
Table 7: GlaxoSmithKline Plc: key financials (£) 22
Table 8: GlaxoSmithKline Plc: key financial ratios 22
Table 9: Novartis AG: key facts 24
Table 10: Novartis AG: key financials ($) 25
Table 11: Novartis AG: key financial ratios 26
Table 12: Pfizer Inc.: key facts 28
Table 13: Pfizer Inc.: key financials ($) 29
Table 14: Pfizer Inc.: key financial ratios 29
Table 15: Czech Republic size of population (million), 2009-13 31
Table 16: Czech Republic gdp (constant 2000 prices, $ billion), 2009-13 31
Table 17: Czech Republic gdp (current prices, $ billion), 2009-13 31
Table 18: Czech Republic inflation, 2009-13 32
Table 19: Czech Republic consumer price index (absolute), 2009-13 32
Table 20: Czech Republic exchange rate, 2009-13 32

LIST OF FIGURES

Figure 1: Czech Republic pharmaceuticals market value: $ billion, 2009-13 8
Figure 2: Czech Republic pharmaceuticals market geography segmentation: % share, by value, 2013 9
Figure 3: Czech Republic pharmaceuticals market share: % share, by value, 2013 10
Figure 4: Czech Republic pharmaceuticals market value forecast: $ billion, 2013-18 11
Figure 5: Forces driving competition in the pharmaceuticals market in the Czech Republic, 2013 12
Figure 6: Drivers of buyer power in the pharmaceuticals market in the Czech Republic, 2013 13
Figure 7: Drivers of supplier power in the pharmaceuticals market in the Czech Republic, 2013 15
Figure 8: Factors influencing the likelihood of new entrants in the pharmaceuticals market in the Czech Republic, 2013 16
Figure 9: Factors influencing the threat of substitutes in the pharmaceuticals market in the Czech Republic, 2013 18
Figure 10: Drivers of degree of rivalry in the pharmaceuticals market in the Czech Republic, 2013 19
Figure 11: GlaxoSmithKline Plc: revenues and profitability 22
Figure 12: GlaxoSmithKline Plc: assets and liabilities 23
Figure 13: Novartis AG: revenues and profitability 26
Figure 14: Novartis AG: assets and liabilities 27
Figure 15: Pfizer Inc.: revenues and profitability 30
Figure 16: Pfizer Inc.: assets and liabilities 30

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

  • $ 10995
  • Industry report
  • September 2016
  • by Global Data

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024 Summary Attention deficit hyperactivity disorder (ADHD) is characterized by excessive levels ...

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

  • $ 7000
  • Industry report
  • August 2016
  • by Frost & Sullivan

Emerging Business Models Drive Transformation The key objective of this research is to provide in-depth knowledge of the major global pharmaceutical CMO market segments—active pharmaceutical ingredients ...

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

  • $ 6995
  • Industry report
  • November 2016
  • by GBI Research

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation Summary Asthma is a chronic condition affecting ...


ref:plp2014

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.